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ABSTRACT
Previous studies have analyzed patterns of transcrip-
tion, transcription factor (TF) binding or mapped nu-
cleosome occupancy across the genome. These sug-
gest that the three aspects are genetically connected
but the cause and effect relationships are still un-
known. For example, physiologic TF binding studies
involve many TFs, consequently, it is difficult to as-
sign nucleosome reorganization to the binding site
occupancy of any particular TF. Therefore, several
aspects remain unclear: does TF binding influence
nucleosome (re)organizations locally or impact the
chromatin landscape at a more global level; are all or
only a fraction of TF binding a result of reorganization
in nucleosome occupancy and do all TF binding and
associated changes in nucleosome occupancy result
in altered gene expression? With these in mind, fol-
lowing characterization of two states (before and af-
ter induction of a single TF of choice) we determined:
(i) genomic binding sites of the TF, (ii) promoter
nucleosome occupancy and (iii) transcriptome pro-
files. Results demonstrated that promoter-proximal
TF binding influenced expression of the target gene
when it was coupled to nucleosome repositioning at
or close to its binding site in most cases. In contrast,
only in few cases change in target gene expression
was found when TF binding occurred without local
nucleosome reorganization.
INTRODUCTION
Although transcription factors (TFs) can recognize cognate
binding sites on the nucleosomal surface, functional bind-
ing is almost always associated with chromatin modifica-
tion, remodeling and finally displacement or compaction of
nucleosomes. Specific epigenetic signals determine the site
and state of this reorganization based on the bound TF,
leading to cellular differentiation. Modification of the cel-
lular phenotype from a group or ‘community’-like (epithe-
lial) state to a more solitary (mesenchymal) form (epithelial
to mesenchymal transition, EMT) is a basic developmental
feature that has beenwell studied (reviewed in (1,2)).Metas-
tasis or spreading of cancer from the site of origin is also
manifested with enhanced mesenchymal features in tumor
cells (3,4). In this context, though gene expression networks
for the EMT are well studied, regulation of the nucleosomal
or chromatin state is poorly understood (5).
Though there are several minor variations, the overall
chromatin architecture of a given transcription unit may be
summarized as: a ‘−1’ nucleosome positioned upstream of
the transcription start site (TSS), a nucleosome-free region
(NFR) followed by a ‘+1’ nucleosome downstream of TSS,
in addition to an array of positioned nucleosomes through-
out the gene body (6). This basic organization is stabilized
by modified histones or histone variants placed at specific
regions within genes (7,8). Organizational change in chro-
matin such as altered positioning of the +1 and/or −1 nu-
cleosome with resultant change in the NFR (9), altered
inter-nucleosomal spacing due to chromatin compaction
(10–12) and/or histone variant occupancy near TSS (13)
may result in transcriptional response (14–16). Together
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these can modulate accessibility of genomic DNA in vivo
toward binding of TFs (6). This model is supported by
high-resolution nucleosomemaps generated for human pro-
moters by subjecting chromatin to micrococcal nuclease
(MNase) and detecting the undigested DNA with tiling ar-
rays (17) or deep sequencing (MNase-Seq) (15).
By employing the yeast system, nucleosome dynamics
during transcriptional changes has been investigated in de-
tail. It was found that nucleosome reorganization as a re-
sult of physiological perturbations by means of heat-shock
induced large-scale transcriptome changes in yeast. How-
ever, at the nucleosomal level, most changes were limited
to one or two nucleosomes per promoter (16). Further-
more, genome-wide analysis of nucleosome dynamics dur-
ing meiotic development in yeast revealed dramatic reor-
ganization of chromatin (9). A combined analysis of nu-
cleosome architecture, transcriptional states and status of
DNA binding factors from publicly available data sets in
yeast suggestedDNAbinding factorsmay control promoter
nucleosome architecture (18). Other studies found that nu-
cleosome repositioning events may facilitate TF binding
and gene expression upon androgen treatment (19), during
differentiation of hematopoietic stem cells to erythrocytes
(20), or interferon-beta activation following virus infection
(21). Together, these suggest a process where nucleosome
remodelers, general TFs and the transcriptional elongation
machinery together orchestrate the nucleosome-positioning
pattern in vivo (22–24).
This understanding prompts further interesting ques-
tions regarding both the nature of TF/nucleosome inter-
actions and to what extent this influences transcriptional
response. For example, in earlier studies, induced physio-
logical perturbations activated multiple TFs (19–21), it is
not clear how unique site-specific TF binding influences nu-
cleosome (re)organizations locally (in close vicinity of their
binding sites). Another pertinent question is: do all sites
occupied by a TF, and associated nucleosome occupancy
changes result in altered gene expression? Keeping these in
mind, we sought to study binding of single TF that would
also induce the physiological change. A candidate TF was
first identified fromanalysis of early and advanced lung can-
cer transcriptome profiles. In vivo binding sites of the TF,
nucleosome positions and transcriptome profiles of both
themetastatic and induced non-metastatic state in lung can-
cer cells were then determined (see Scheme S1 in Supple-
mentary Information for a summary of the overall design)
and using these, the correlation between target site occu-
pancy, nucleosome reorganization and their combined ef-
fect on the transcriptome was examined. Results that sug-
gest a model where TF binding coupled with nucleosome
reorganizations that influence transcription are: (i) almost
always associated with nucleosome repositioning that is at
close proximity to the TF binding site (TFBS) and (ii) con-
strained to specific loci, and not spread over the whole
genome.
MATERIALS AND METHODS
Chromatin immunoprecipitation and sequencing
Chromatin immunoprecipitation (ChIP) assays were per-
formed following the Fast ChIP protocol (25). Briefly, two
plates were made with 1× 105 A549 cells in each, on achiev-
ing 80% confluency the first plate was transfected with
the clone pcDNA3-NME2-Myc to induce non-metastatic 2
(NME2). The second plate was left untreated (un-induced
condition). After 48 h, ChIP was performed using cells
from each plate independently and cells were fixed with 1%
formaldehyde for 10min, lysed and sheared (∼300 bp) using
aMisonix 3000 sonicator. Twenty-five per cent of lysate was
used to isolate input chromatin using phenol–chloroform
and ethanol precipitation. The remaining lysate was pre-
cleared using protein-A sepharose beads and further di-
vided into two equal portions: one part was immunopre-
cipitated using antibody specific to the Myc epitope (clone
9E10, anti-c-Myc monoclonal, Sigma) and a negative con-
trol of immunoprecipitation was prepared by adding iso-
typic control (IgG) to the second portion. Immunoprecipi-
tation was done by incubating overnight at 4◦Cwith 2g of
antibody. The un-induced experiment was treated in a simi-
lar fashion before immunoprecipitation with nm23-h2-L-16
antibody (sc-17587, Santa Cruz Biotechnology Inc.); IgG
was used as the respective isotypic control. Immune com-
plexes were collected using herring sperm DNA-saturated
protein-A Sepharose, washed and eluted using Chelex-100
after proteinase K treatment. Reads were aligned (mapped)
to the unmasked human reference genome (NCBI v36,
hg18) using the MAQ (Mapping and Assembly with Qual-
ities) (26) after clipping to 24 bp based on quality scores.
The sequences were then mapped to the reference human
genome (NCBI Build 36, UCSC hg18). Only those that
aligned to the reference genome were further considered
for peak generation. To accommodate variations relative to
the reference genome, up to two mismatches were allowed.
Commercially available small interfering RNAs (siRNAs)
from Dharmacon, Inc. USA, were used to silence expres-
sion of NME2 (transient depletion) in A549 wherever re-
quired.
Peak generation following ChIP-seq
The resulting sequence read distribution was processed
with ChIP-Seq peak locator utility, CisGenome (26).
CisGenome uses a conditional binomial model to identify
regions in which the ChIP reads are significantly enriched
relative to the control reads. A false discovery rate of 10%
was considered while predicting NME2 target regions. In
order to filter out low-quality sites we applied two post-
processing options boundary refinement and single-strand
filtering.
Mononucleosome preparation and hybridization to promoter
tiling array
A549 cells (NME2-induced or -depleted, along with respec-
tive control cells) were grown in T-75 flasks till 80% conflu-
ency in Dulbecco’s modified Eagle’s medium, trypsinized,
pelleted and washed with ice-cold 1X phosphate buffered
saline. Five times the packed pellet volume of 1X hypo-
tonic buffer was added, cells homogenized, IGEPAL (a
non-ionic, non-denaturing detergent) was added to final
concentration of 0.6% lysate, vortexed and centrifuged at 12
000 revolutions per minute. Pellet (nuclei) was resuspended
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in MNase digestion buffer and incubated on ice. OD (Op-
tical Density) was measured and 1 unit of MNase/OD was
added to the suspension. Following incubation at 37oC for
30 min the reaction was stopped using stop-buffer, treated
with proteinase K (1 mg/ml) overnight at 37oC before
phenol–chloroform purification and ethanol precipitation
to pellet down the mononucleosomal DNA. Precipitated
DNA was washed with 70% alcohol and dissolved in wa-
ter. DNase-treated cells were taken as control.Mixture con-
taining 3 g of DNA, 50 mMTris-Cl, 5 mMMgCl2 and 0.3
g/l of random hexamers was incubated at 95oC for 5min
and chilled to 4oC. 5l dNTP (1.2mMdGTP, dCTP, dATP
and 0.25 mM dUTP) and 50 units of Klenow were incu-
bated first at 22oC for 10 min, then 37oC for 30 min and
finally 95oC for 5 min and chilled as above. Fifty units of
Klenow were added again and the mix first kept at 22oC for
10 min and then 37oC for 30 min. Reaction was stopped
by phenol–chloroform followed by purification using Qia-
gen columns. Purified product was fragmented and labeled
as per Affymetrix Chromatin Immunoprecipitation Assay
protocol before hybridization to Gene Chip Human Pro-
moter Tiling array 1.0R (Affymetrix) as per manufacturer’s
protocol. The control DNase-treated cells were also sub-
jected to labeling reactions as above before hybridization.
Nucleosome positions were identified using iChIP (Biocon-
ductor package).
Nucleosome occupancy analysis
A549 cells depleted for NME2 were generated using com-
mercially available short hairpin RNAs (from Origene Inc.,
USA; catalog no. TR311160) and stable cell clones were
selected in presence of puromycin. For analysis of nucle-
osome repositioning, we considered a distance of 300 bp
(+/− 150 bases), in other words, a nucleosome was denoted
as repositioned in the NME2-induced condition when de-
tected beyond 300 bp of a nucleosome found in the cells
before NME2 induction. In order to avoid arbitrary assign-
ments, in cases where a gene belonged to more than one
category (while assigning NME2 nucleosome associations
during repositioning analysis (Figure 5)) it was considered
in all the respective cases.
Quantitative real-time PCR for validating ChIP-nucleosome
positioning
For validating individual nucleosome positions, quantita-
tive real-time PCRs were performed using ChIPped DNA
on ABI’s (Applied Biosystems, Inc.) 7500 fast platform.
Equal concentration of ChIP DNA was taken from the
test (from NME2-induced cells) and contro‘l (un-induced)
samples. The results were analyzed using comparative com-
puted tomography method. Primers were designed against
the obtained peak region using ABI’s Primer Express soft-
ware (Supplementary Table S1).
Western blotting
Western blot for NME2 was done using antibody from Ab-
cam, Cambridge, MA, USA (catalog no. ab60602). Actin
was probed by antibody from Sigma (catalog no. 1978).
The gene expression, nucleosome positioning and ChIP-
seq data have been submitted to Gene Expression Omnibus
(http:/www.ncbi.nlm.nih.gov/geo/) under accession num-
bers GSE40194, GSE40300, GSE40363 and GSE18182.
RESULTS
We analyzed expression of 1722 regulatory factors, includ-
ing ones involved in cancer metastasis (27–29), in transcrip-
tome profiles of 382 lung cancer clinical cases. Our analyses
identified that a metastasis suppressor NME2 (also known
as NM23 H2/NDPK) was significantly down regulated in
advanced stages across four independent data sets (P <
0.05, student’s t-test; Supplementary Figure S1a). Details
of this analysis including further experiments performed by
us which confirmed that NME2 can induce anti-metastatic
changes in lung adenocarcinoma-derived A549 cells are
provided as supplementary material (Supplementary Infor-
mation and Supplementary Figures S1b–d). Next, we deter-
mined NME2 occupancy, nucleosome positions and tran-
scriptomes before and after induction of NME2 levels in
A549 cells. As NME2 is endogenously expressed in A549
cells, we used the term ‘NME2 induced’ to refer to the cel-
lular state following increase of NME2 levels. To ascertain
whether NME2 protein level after induction in A549 cells
was still in the physiological range, we analyzed protein ex-
pression of NME2 in normal lung lysates and tumor lung,
and compared with NME2-induced A549 cells. Our com-
parative analysis clearly showed that NME2 level within in-
duced A549 cells were within physiological range (Supple-
mentary Figure S1e).
Genome-wide NME2 binding, promoter-nucleosome occu-
pancy and the transcriptional state
ChIP followed by massively parallel sequencing (ChIP-seq)
was performed in replicate for both conditions, before and
after inducing NME2 (Figure 1A). Out of roughly 7 mil-
lion sequence reads,>80% uniquely aligned to the reference
human genome in each case (Supplementary Figure S2a).
Using ChIP-seq reads enriched in NME2 relative to IgG,
we found 2005 and 11 017 peaks before and after induc-
ing NME2 in A549 cells, respectively. Although, number of
NME2 binding sites increased after induction, a close in-
spection of peaks (sites of NME2 binding to DNA) showed
that their chromosome-wise distribution was largely similar
in both cases (Figure 1A: Circos plot, and Supplementary
Figures S2b and c). The replicates were also similar (Figure
1A: Circos plot, and Supplementary Figure S2d). The fre-
quency of TFBSs was also largely similar before and after
induction of NME2 (Supplementary Figure S2e). A 12-mer
consensus motif identified using Gibbs sampler (30) was
present in >70% of the ChIP-seq peaks (Figure 1B upper
panel). We noted that the motif found from ChIP-seq was
similar to the one reported earlier from analysis of a single
promoter (31) and unpublished data of Thakur et al. (sub-
mitted for publication) As expected, inmore than 50% cases
the NME2 motif occurred within 50 bp of the center of
peak (Figure 1B lower panel).We next performed transcrip-
tome profiling of A549 cells before and after NME2 in-
duction. Comparative analysis of the expression profiles re-
vealed 1679 genes as differentially expressed (781 genes were
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Figure 1. NME2 binding sites before or after inducing NME2. (A) A Circos plot showing ChIP-seq peak distribution of NME2 on all chromosomes (1–22,
and X and Y); peaks in red represent NME2 binding sites before induction; peaks in blue represent NME2 binding sites after induction (replicates are
shown in both cases). Two projections from chromosomes 9 and 15 are shown. (B) Twelve-mer consensus NME2 binding motif identified using Gibbs
sampler (upper panel)––distribution of the 12-mer motif within NME2 peaks constructed from read counts is shown in the lower panel.
 by guest on N
ovem
ber 29, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
9606 Nucleic Acids Research, 2014, Vol. 42, No. 15
Figure 2. Nucleosome positions detected in A549 cells before and after inducing NME2. (A) UCSC browser representation of nucleosome positions with
corresponding probe intensity at two loci on chromosome 12. (B) Nucleosome occupancy around TSS and expression level of corresponding genes in cells
before (left panels) and after NME2 induction (right panels); gene expression was normalized within respective cases by z-transformation with respect to
the mean expression level of the data sets. (C) Frequency of occurrence and location of nucleosomes around TSS. −1, +1, +2, +3, +4 denote sequential
presence of nucleosomes with respect to their occurrence from TSS; percentage of total number of nucleosomes found in respective cases, before or after
induction of NME2. (D) Left panel: distribution of repositioned nucleosomes around TSSs in NME2-induced cells relative to the status in cells before
NME2 was induced; number of repositioned nucleosomes in a window size of 100 bp is shown on top. Right panel: expression of corresponding genes
shown in triplicate before and after NME2 induction.
up and 898 genes down regulated (P < 0.05)) in NME2-
induced cells; out of these we found at least one NME2
binding site (in the induced condition) within 10 kb of the
TSS in as many as 1235 genes.
We next asked whether altered state of chromatin in reg-
ulatory regions influenced NME2 occupancy and conse-
quent gene expression changes. To test this, nucleosome po-
sitions were determined in the A549 cells before and af-
ter NME2 induction. Mono-nucleosomes were isolated by
MNase digestion and we mapped nucleosome positions to
putative promoter regions (−7.5 kb to 2.5 kb of TSSs) using
tiled microarrays (Figure 2A) and found 157 634 and 162
570 nucleosomes before and after NME2 induction, respec-
tively. Next, we checked the relationship between overall
number of nucleosomes on each promoter and the expres-
sion level of corresponding gene and found that enriched
promoter-nucleosome occupancy correlated with decreased
expression of corresponding genes (r= −0.73; P< 0.05 be-
fore NME2 induction and r= −0.80; P< 0.05 after NME2
induction, Pearson correlation; Figure 2B).
Target site proximal promoter-nucleosome repositioning
upon NME2 expression
We noted distinct occurrence of nucleosomes with respect
to TSSs across promoters for many genes, which showed
a phased pattern that was consistent with previous studies
of nucleosome distribution in human and yeast (15,32,33)
(Figure 2C). On comparing the two states, before and after
NME2 induction, we found ∼11.4% (18 024/157 634) nu-
cleosomes on 1022 genes were repositioned in the NME2-
induced condition. We also found that a large number of
genes with repositioned nucleosomes were differentially ex-
pressed between the two states (830 out of 1022 genes (P <
0.05)) (Figure 2D). It is important to note that in contrast to
Figure 2B which showed that a high overall increased num-
ber of nucleosomes on a given promoter relates to decreased
expression, Figure 2D showed that differential expression
of genes here resulted from repositioning (and not overall
exclusion or gain) of nucleosomes within promoter. Inter-
estingly, most repositioning events after NME2 induction
were observed near TSSs (Figure 2D, upper panel).
We next checked target-site nucleosome occupancy be-
fore and after NME2 induction (Figure 3A). On analyzing
relative occurrence we found lower number of positioned
nucleosomes in the vicinity (∼300–500 bp) of NME2 tar-
get sites in cells after NME2 induction (Figure 3B). Out of
3956 NME2 target sites (within −7.5 to +2.5 kb of TSS)
unique to the NME2-induced cells, 1257 (31%) present on
1119 putative promoters were found to either overlap or
were within 300 bases of a nucleosome in cells beforeNME2
induction. Furthermore, 870 (∼70%) of the 1257 sites were
found to be nucleosome-free in the NME2-induced condi-
tion, which involved repositioning of 870 nucleosomes in
791 genes on NME2 induction. Together, these findings in-
dicate that many of the NME2 binding sites occupied by
nucleosomes in the un-induced condition in A549 cells be-
came NME2-bound (and nucleosome-free) in the NME2-
induced condition.
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Figure 3. Nucleosome depletion and NME2 occupancy. (A) Schematic representation of possible relationship between nucleosome positions before and
after inducing NME2. (B) Nucleosome occupancy is depleted on or near NME2 binding sites on inducing NME2 relative to the condition before NME2
induction. Ratio of number of nucleosomes detected after/before NME2 induction in 300 bp windows is shown; x-axis denotes the distance of nucleosomes
from the nearest NME2 binding site in NME2-induced cells. (C) Schematic representation of nucleosome shift between two conditions was represented by
Ndisplacement (left panel). Percentage of shifted nucleosomes plotted for a given Ndisplacement is shown in the right panel (x-axis was plotted to indicate:
no shift, shift in 100 bp windows and shift exceeding 300 bases). Distribution of the nucleosome shift was also found for the NME2-depleted condition
minus A549 cells; significance of the difference in distributions was tested using the Wilcoxon rank sum test (P = 0.00016). (D) Position of the nearest
nucleosome with respect to NME2 binding sites in cells before (green) or after inducing NME2 (red; left panels); 791 genes where the nearest nucleosome
was within 300 bp and shifted in the NME2-induced condition are shown. Expression level of corresponding genes in triplicate before or after NME2
induction is shown in the right panels.
To analyze nucleosome repositioning with respect to the
NME2 target site after versus before NME2 induction, we
calculated the distance of nucleosome shift between the
two conditions as Ndisplacement (Figure 3C, left panel) and
found ∼64% nucleosomes shifted by more than 300 bp in
the NME2-induced condition. In order to test the signif-
icance of the noted nucleosome shift, we also calculated
this distribution in A549 cells where NME2 was depleted
(see below) relative to control A549 cells. Observed dis-
tributions were significantly altered following induction of
NME2; in contrast, onNME2 depletionwe did not find any
repositioning in most cases (Wilcoxon rank sum test; P =
0.00016; Figure 3C, right panel). Next we plotted the 870-
nucleosome positions (found within 300 bp of an NME2
target site in the un-induced condition) before and after
NME2 induction. This showed a loss in organized nucle-
osome occurrence around NME2 binding sites in NME2-
induced cells relative to the un-induced condition (Figure
3D). We further noted that expression of all the 791 genes
with repositioned nucleosomes was significantly altered in
the NME2-induced condition (P < 0.05, student’s t-test,
Figure 3D). For validation, we compared nucleosome oc-
cupancy and NME2 binding using quantitative real-time
PCR in six genes. In all cases, low nucleosome occupancy
signal was detected along with high NME2 occupancy in
cells after NME2 induction as compared to that observed
in un-induced cells (Figure 4).
Target sites are nucleosome occupied in cells with depleted
levels of NME2
We reasoned that in addition to induced NME2; A549 cells
with depleted levels of NME2 would provide a suitable
model to test nucleosome positioning/NME2 occupancy in
a contrasting situation. To test this, we generated a stable
NME2-depleted A549 cell line (see Materials and Meth-
ods). Following this we determined nucleosome positions in
the NME2-depleted cells. All the 870 NME2 binding sites
that were nucleosome-free in the NME2-induced condition
and occupied in the un-induced state (Figure 3D) were also
found to be nucleosome-occupied in the NME2-depleted
condition. To further functionally validate this point, we
show two promoters where the NME2 target site was not
occupied by NME2 and had positioned nucleosomes in
A549 cells and NME2-depleted A549 cells but were avail-
able for NME2 binding following NME2 induction (Sup-
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Figure 4. Validation by quantitative real-time PCR (Polymerase Chain Reaction) for NME2 binding and nucleosome occupancy. Nucleosome positions
and NME2 binding sites are shown before and after NME2 induction at six different loci in the left panel (genes shown in UCSC browser representation);
right panel shows validation at the corresponding loci by quantitative real-time PCR for NME2 binding and nucleosome occupancy in cells before and
after inducing NME2. Relative fold change is shown on x-axis. Experiments were performed in triplicate; error bars are for standard deviation (* and **
represent P < 0.05 and P < 0.01, respectively).
plementary Figure S3). In case of 53 genes, we found po-
sitioned nucleosomes on or near NME2 target sites on
NME2 depletion relative to control A549 cells. Together
this suggests that in contrast to the nucleosomal changes
following increase in NME2 expression, NME2 target sites
remain nucleosome-occupied in most cases on depletion of
NME2.
Binding site occupancy is transcriptionally active when asso-
ciated with nucleosome repositioning
We found that occupancy of about a fifth (870 of 3956
NME2 target sites, ∼22%) of the transcription target sites
was concurrent with repositioning of nucleosomes in the
NME2-induced condition. Interestingly, these reposition-
ing events resulted in altered expression of all the 791 genes
(Figure 3D). In contrast, we found 1175 genes where the
NME2 binding site (unique to the induced condition) was
co-occupied with nucleosomes––only 130 (11%) of these
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Figure 5. TF binding and nucleosome repositioning models analyzed in this study. Nucleosome shift in the vicinity of TF binding results in repositioning
of the −1 nucleosome (upper panel), whereas co-occupancy (center panel) or target site binding that has no associated nucleosome repositioning in close
vicinity either before or after induction of the TF (lower panel) shows no significant change in −1 or +1 nucleosome positions. Percentage of nucleosomes
is based on genome-wide total for respective cases; to avoid arbitrary assignment genes were considered in more than one category where applicable.
genes showed altered expression. As a third possibility, we
found 1990 genes with NME2 occupancy in the induced
condition though no nucleosomes were present in the vicin-
ity of the NME2 site either before or after induction––i.e.
target sites appeared to be independent of nucleosome repo-
sitioning. Again, out of 1990, only 179 (8.9%) genes were
differentially expressed. On mapping the NFR between the
−1 and +1 nucleosome positions in each of the three sit-
uations described above, we found repositioning of the −1
nucleosome by ∼40 bp in the first case when repositioning
was linked to binding site occupancy, whereas in the other
two situations the NFR was minimally altered on inducing
NME2 (Figure 5).
DISCUSSION
Our findings suggest that TF binding when closely associ-
ated with nucleosome repositioning results in altered gene
expression changes. Interestingly, in most cases when TF
binding did not impact local nucleosome reorganization it
was not associated with altered transcriptional state of tar-
get gene. As we used human cancer cells that are metastatic,
and expression of the TF NME2 decreased their metastatic
potential, these findings also help in understanding how
TF binding-induced nucleosome level changes influence the
transcriptome during metastasis.
TF binding and transcriptional activity are linked through lo-
cal nucleosome repositioning
It was recently reported that repositioning of the +1 nucle-
osome resulted in changes to NFR in genes that were dif-
ferentially regulated during meiotic development in yeast
(9). Though this was noted as a result of change in pos-
sibly multiple regulatory factors involved in meiotic devel-
opment, it is consistent with our results. Furthermore, our
findings indicate that assignment of transcriptional func-
tion to genome-wide target site binding would require infor-
mation on nucleosome reorganization to be more precise.
This helps explain the noted discrepancy in high through-
put DNA binding studies where low overlap between ex-
perimentally determined binding sites and gene expression
has been observed (34,35). A recent study noted chromatin
accessibility before and after binding of the receptors (an-
drogen (AR) or estrogen (ESR1)) were significantly altered
(19) and suggested that both AR and ESR1 binding are as-
sociated with changes in local nucleosome occupancy. This
is in line with our findings and suggests a model that inte-
grates factor binding and transcriptional activity of genes
with local nucleosomal changes.
Non-specific binding of NME2 in the induced condi-
tion could be a confounding factor. To address this, first,
we checked and found that in NME2-depleted cells a large
number of genes were oppositely expressed with respect to
their status in NME2-induced cells; it is unlikely that non-
specifically activated/repressed genes as a result of NME2
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induction would be differentially expressed on depleting
NME2 (Supplementary Figure S4). Second, the differen-
tially expressed genes in NME2-induced cells correlate sig-
nificantly with transcriptome changes that are clinically rel-
evant (Supplementary Figure S5). Therefore, though all
NME2 binding events do not lead to increase/decrease in
transcription it is unlikely to be due to spurious binding––it
is possible that many of these associations are required for
functions other than transcription.
Overall chromatin landscape in promoters is largely constant,
site-specific changes are associated with transcription
We found only 11.4% of nucleosomes to be repositioned
in promoter proximal regions as a result of NME2 induc-
tion. Therefore, it is interesting to consider that overall chro-
matin level changes may be relatively small. On the other
hand, and perhaps more interestingly, there may be shift
in nucleosome occupancy on TF binding, leading to site-
specific ‘open’ or ‘closed’ regions that facilitate regulatory
events. Our findings (discussed above) further support this:
nucleosomes repositioning along with engagement of TF at
specific sites were in almost all cases associated with tran-
scriptional change in the corresponding gene. In addition,
in both cases before and after NME2 induction, enriched
promoter nucleosome occupancy correlated with decreased
expression of genes. Together these support a model where
nucleosome occupancy generally determines the suppressed
state of the transcriptome, and reorganization induced by
DNA binding factors (themselves or when associated with
chromatin modifiers) results in transcriptional activation at
specific loci. Although further studies using other TFs will
be required to substantiate this, it appears to be consis-
tent with an earlier study which observed decreased pres-
ence of nucleosomes in promoters of genes that were ex-
pressed during heat shock in yeast (16). However, others
have also noted either unchanged nucleosome occupancy
(yeast grown in different carbon sources (36,37)) or found
nucleosome positioning to correlate with the state of tran-
scription (active or silent), and not the extent of gene ex-
pression (18).
Epigenetic signaling directs the location of TFs to cog-
nate sites in given chromatin territories. Following this, TFs
are believed to be one of the key recruiters of chromatin
modification and remodeling machineries (38–40). Recent
evidence suggests that even the general TFs, such as subunit
of TFIID (Transcription Factor II D) complexes, may be
functional component of these machineries (41). In agree-
mentwith this basic understanding of transcription through
chromatin, our results demonstrate TF binding to be tran-
scriptionally competent when coupled with locally altered
nucleosome positioning. Furthermore, our findings for the
first time underline the importance of these aspects of chro-
matin biology in suppression of cancer spread mediated
by NME2. However, it remains to be elucidated whether
NME2-mediated alteration of nucleosomal reorganization
possesses any unique features of the histone modification
language (involving specific enzyme complexes and histone
chaperones) that could be essential in mitigating metastasis.
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